Darwin Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Darwin Advisors, LLC

  • $356 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021
SELL
$574.03 - $680.96 $271,516 - $322,094
-473 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $223,634 - $264,189
473 New
473 $264,000
Q3 2020

Oct 16, 2020
SELL
$544.75 - $658.21 $2.58 Million - $3.11 Million
-4,728 Closed
0 $0
Q2 2020

Aug 06, 2020
BUY
$493.32 - $643.92 $2.33 Million - $3.04 Million
4,728 New
4,728 $2.95 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email